| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
British Medical Bulletin 63:73-94 (2002)
© 2002 The British Council
Hereditary deafness and phenotyping in humans
Unit of Clinical and Molecular Genetics, Institute of Child Health, London, UK
Hereditary deafness has proved to be extremely heterogeneous genetically with more than 40 genes mapped or cloned for non-syndromic dominant deafness and 30 for autosomal recessive non-syndromic deafness. In spite of significant advances in the understanding of the molecular basis of hearing loss, identifying the precise genetic cause in an individual remains difficult. Consequently, it is important to exclude syndromic causes of deafness by clinical and special investigation and to use all available phenotypic clues for diagnosis. A clinical approach to the aetiological investigation of individuals with hearing loss is suggested, which includes ophthalmology review, renal ultrasound scan and neuro-imaging of petrous temporal bone. Molecular screening of the GJB2 (Connexin 26) gene should be undertaken in all cases of non-syndromic deafness where the cause cannot be identified, since it is a common cause of recessive hearing impairment, the screening is straightforward, and the phenotype unremarkable. By the same token, mitochondrial inheritance of hearing loss should be considered in all multigeneration families, particularly if there is a history of exposure to aminoglycoside antibiotics, since genetic testing of specific mitochondrial genes is technically feasible.
Most forms of non-syndromic autosomal recessive hearing impairment cause a prelingual hearing loss, which is generally severe to profound and not associated with abnormal radiology. Exceptions to this include DFNB2 (MYO7A), DFNB8/10 (TMPRSS3) and DFNB16 (STRC) where age of onset may sometimes be later on in childhood, DFNB4 (SLC26A4) where there may be dilated vestibular aqueducts and endolymphatic sacs, and DFNB9 (OTOF) where there may also be an associated auditory neuropathy. Unusual phenotypes in autosomal dominant forms of deafness, include low frequency hearing loss in DFNA1 (HDIA1) and DFNA6/14/38 (WFS1), mid-frequency hearing loss in DFNA8/12 (TECTA), DFNA13 (COL11A2) and vestibular symptoms and signs in DFNA9 (COCH) and sometimes in DFNA11 (MYO7A). Continued clinical evaluation of types and course of hearing loss and correlation with genotype is important for the intelligent application of molecular testing in the next few years.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. M. Ardle and M. Bitner-Glindzicz Investigation of the child with permanent hearing impairment Arch. Dis. Child. Ed. Pract., February 1, 2010; 95(1): 14 - 23. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Vandebona, P. Mitchell, N. Manwaring, K. Griffiths, B. Gopinath, J. J. Wang, and C. M. Sue Prevalence of Mitochondrial 1555A->G Mutation in Adults of European Descent N. Engl. J. Med., February 5, 2009; 360(6): 642 - 644. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Manwaring, M. M. Jones, J. J. Wang, E. Rochtchina, C. Howard, P. Newall, P. Mitchell, and C. M. Sue Mitochondrial DNA Haplogroups and Age-Related Hearing Loss Arch Otolaryngol Head Neck Surg, September 1, 2007; 133(9): 929 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ali, P. T. Christie, I. V. Grigorieva, B. Harding, H. Van Esch, S. F. Ahmed, M. Bitner-Glindzicz, E. Blind, C. Bloch, P. Christin, et al. Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor Hum. Mol. Genet., February 1, 2007; 16(3): 265 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yagi, H. Tokano, M. Maeda, T. Takabayashi, T. Nagano, H. Kiyama, S. Fujieda, K. Kitamura, and M. Sato Vlgr1 is required for proper stereocilia maturation of cochlear hair cells. Genes Cells, February 1, 2007; 12(2): 235 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Garringer, N. D. Pankratz, W. C. Nichols, and T. Reed Hearing Impairment Susceptibility in Elderly Men and the DFNA18 Locus. Arch Otolaryngol Head Neck Surg, May 1, 2006; 132(5): 506 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Mytton and I. Mackenzie Observed and expected prevalence of permanent childhood hearing impairment in Oldham J Public Health, September 1, 2005; 27(3): 298 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Bhattacharya, E. J. Rockwood, S. D. Smith, V. L. Bonilha, J. S. Crabb, R. W. Kuchtey, N. G. Robertson, N. S. Peachey, C. C. Morton, and J. W. Crabb Proteomics Reveal Cochlin Deposits Associated with Glaucomatous Trabecular Meshwork J. Biol. Chem., February 18, 2005; 280(7): 6080 - 6084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Jen, H. Wang, H. Lee, C. Sabatti, R. Trent, I. Hannigan, K. Brantberg, G. M. Halmagyi, S. F. Nelson, and R. W. Baloh Suggestive linkage to chromosome 6q in families with bilateral vestibulopathy Neurology, December 28, 2004; 63(12): 2376 - 2379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ishiyama, G. Ishiyama, I. Lopez, J. Jen, G. Kim, and R. W. Baloh Temporal bone histopathology in dominantly inherited audiovestibular syndrome Neurology, November 23, 2004; 63(10): 1859 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Ceranic and L M Luxon Progressive auditory neuropathy in patients with Leber's hereditary optic neuropathy J. Neurol. Neurosurg. Psychiatry, April 1, 2004; 75(4): 626 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Marziano, S. O. Casalotti, A. E. Portelli, D. L. Becker, and A. Forge Mutations in the gene for connexin 26 (GJB2) that cause hearing loss have a dominant negative effect on connexin 30 Hum. Mol. Genet., April 15, 2003; 12(8): 805 - 812. [Abstract] [Full Text] [PDF]
|
|